AN2 Therapeutics (ANTX) vs Canton Strategic (CNTN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
AN2 Therapeutics (ANTX) has outperformed Canton Strategic (CNTN) over the past year, gaining 262.8% versus a loss of 34.6%. Canton Strategic is the larger company by market cap ($167.7 million vs $165.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANTX | CNTN |
|---|---|---|
| Share price | $4.38 | $2.11 |
| Market cap | $165.28M | $167.73M |
| 1-day change | -6.41% | +1.20% |
| YTD return | +310.53% | -31.35% |
| 1-year return | +262.79% | -34.59% |
| EPS (TTM) | $-1.05 | $-0.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.19 | $6.89 |
| 52-week low | $1.00 | $1.75 |
| Distance from 52-week high | -39.08% | -69.45% |
| Analyst consensus | none | — |
| Avg. price target upside | +105.48% | — |
| Average volume | 240.21K | 758.86K |
| Shares outstanding | 37.74M | 79.68M |
| Employees | 21 | 12 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANTX has outperformed CNTN by 297.4 percentage points over the past year.
About AN2 Therapeutics
ANTX stock →AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company's initial candidate includes epetraborole, which is phase 3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease, as well as studying for the treatment of acute melioidosis.
Health Care · Biotechnology: Pharmaceutical Preparations · 21 employees
About Canton Strategic
CNTN stock →Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
ANTX vs CNTN FAQ
Which is bigger, AN2 Therapeutics or Canton Strategic?
Canton Strategic (CNTN) is larger, with a market capitalization of $167.73M compared with $165.28M for AN2 Therapeutics (ANTX).
Which stock has performed better over the past year, ANTX or CNTN?
ANTX returned +262.79% over the past 12 months, compared with -34.59% for CNTN (price return, excluding dividends). Past performance does not predict future results.
Are AN2 Therapeutics and Canton Strategic in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.